SFRS11 Activators

The collection of compounds classified as SFRS11 Activators operates indirectly by manipulating the cellular mechanisms surrounding mRNA splicing and processing. The effectiveness of these molecules is rooted in their ability to create a cellular environment that necessitates the enhanced expression or activity of splicing factors like SFRS11. For instance, splicing modulators such as Pladienolide B and Spliceostatin A exert their influence by binding to components of the spliceosome, the intricate molecular machine responsible for splicing pre-mRNA. The binding of these compounds results in impaired spliceosome function, which can signal the cell to compensate by upregulating various splicing factors, including SFRS11, to maintain RNA splicing fidelity. Similarly, Meayamycin and E7107 act on the spliceosome, disrupting its normal function, which may lead to compensatory mechanisms activating SFRS11 expression.

Beyond the spliceosome, chemicals that influence mRNA synthesis and processing indirectly impact SFRS11. Isoquinoline-1,3-dione and Chlorhexidine have the capacity to alter RNA-binding protein dynamics or RNA itself, thereby modulating the splicing machinery and influencing the activity of splicing factors such as SFRS11. Furthermore, Madrasin directly target the splicing machinery, hinting at a possible indirect upregulation of SFRS11 as the cell attempts to restore splicing homeostasis. The actions of H3B-8800, Tetrocarcin A, Amiloride, and Naphthoquinone further illustrate the indirect approach to activating SFRS11.